Nicotinamide Mononucleotide Alleviates Aging Defects in Hutchinson–Gilford Progeria Syndrome
The FASEB Journal · 2025
DOI: 10.1096/fj.202500469rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Yuyan Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Bone Marrow Transplantation Center of the First Affiliated Hospital, and Center for Stem Cell and Regenerative Medicine, Department of Basic Medical …. Hauptthemen laut MEDLINE: Progeria, Nicotinamide Mononucleotide, Aging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Key Research and Development Program of Zhejiang Province (Key R&D plan of Zhejiang Province), MOST | National Natural Science Foundation of China (NSFC), Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Hutchinson–Gilford progeria syndrome (HGPS) is a rare genetic disorder caused by mutations in the LMNA gene, leading to progerin accumulation and accelerated aging. Current therapeutic interventions remain limited. Here, we demonstrate that supplementation with nicotinamide mononucleotide (NMN) markedly ameliorates HGPS‐associated phenotypes at both the cellular and organismal levels. In patient‐derived induced pluripotent stem cell–mesenchymal stem cells, NMN supplementation enhanced NAD + biosynthesis, restored mitochondrial function, reduced DNA damage, and mitigated oxidative stress. Furthermore, 4 months of NMN administration in G608G transgenic mouse models resulted in significant improvements in gonadal function, cardiovascular parameters, skin pathology, and lifespan extension. These comprehensive findings establish NMN supplementation as a promising therapeutic approach for HGPS and potentially other age‐related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bone Marrow Transplantation Center of the First Affiliated Hospital, and Center for Stem Cell and Regenerative Medicine, Department of Basic Medical Sciences, and Liangzhu Laboratory, Zhejiang University School of Medic…
- Center for Reproductive Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Gynecology and Obstetrics, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Center of Gene and Cell Therapy and Genome Medicine of Zhejiang Province, Hangzhou, China.
ORCID-Profile: Yuyan Xu
Förderung
- Key Research and Development Program of Zhejiang Province (Key R&D plan of Zhejiang Province)
- MOST | National Natural Science Foundation of China (NSFC)
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Xu, Y., Wu, M., Fan, Y., Zhang, J., Xue, D., Zhang, M., Shao, R., Cai, L., Liao, X., Zhang, L., & Zhang, J. (2025). Nicotinamide Mononucleotide Alleviates Aging Defects in Hutchinson–Gilford Progeria Syndrome. The FASEB Journal. https://doi.org/10.1096/fj.202500469rr
Vancouver
Xu Y, Wu M, Fan Y, Zhang J, Xue D, Zhang M, et al. Nicotinamide Mononucleotide Alleviates Aging Defects in Hutchinson–Gilford Progeria Syndrome. The FASEB Journal. 2025. doi:10.1096/fj.202500469rr
BibTeX
@article{Xu2025,
author = {Xu, Yuyan and Wu, Mengchen and Fan, Yuhang and Zhang, Jia and Xue, Dixuan and Zhang, Ming and Shao, Rouyi and Cai, Limeng and Liao, Xufeng and Zhang, Ling and Zhang, Jin},
title = {Nicotinamide Mononucleotide Alleviates Aging Defects in Hutchinson–Gilford Progeria Syndrome},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202500469rr}
}
EUVIMED